California Court Rejects Medtronic’s Patent Claims in Blood Pressure Treatment Dispute with Recor

In a recent development, a California federal judge has chosen to dismiss Medtronic Ireland’s counterclaims in its ongoing legal dispute with Recor. Medtronic alleged that Recor’s approach to treating high blood pressure infringes on two of its patents. However, the court found that Medtronic lacked the necessary standing to bring the lawsuit forward, primarily because it had previously licensed these patents to a different entity. For more information on this legal proceeding, [click here](https://www.law360.com/articles/2362452/medtronic-s-blood-pressure-ip-claims-against-recor-get-axed) to read the article detailing the case.